Качественная клиническая практика (Oct 2020)

Rationality of routine clinical use of olokizumab in COVID-19

  • V. M. Tsvetov,
  • A. V. Matveev,
  • D. A. Sychev

DOI
https://doi.org/10.37489/2588-0519-2020-S4-68-70
Journal volume & issue
Vol. 0, no. 4S
pp. 68 – 70

Abstract

Read online

Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials.

Keywords